BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

630 related articles for article (PubMed ID: 12587235)

  • 1. Is it a medical error if we do not screen cirrhotic patients for minimal hepatic encephalopathy?
    Quero Guillén JC; Groeneweg M; Jiménez Sáenz M; Schalm SW; Herrerías Gutiérrez JM
    Rev Esp Enferm Dig; 2002 Sep; 94(9):544-57. PubMed ID: 12587235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management options for minimal hepatic encephalopathy.
    Bajaj JS
    Expert Rev Gastroenterol Hepatol; 2008 Dec; 2(6):785-90. PubMed ID: 19090738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical flicker frequency for diagnosis and assessment of recovery from minimal hepatic encephalopathy in patients with cirrhosis.
    Sharma P; Sharma BC; Sarin SK
    Hepatobiliary Pancreat Dis Int; 2010 Feb; 9(1):27-32. PubMed ID: 20133225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis.
    Liu Q; Duan ZP; Ha DK; Bengmark S; Kurtovic J; Riordan SM
    Hepatology; 2004 May; 39(5):1441-9. PubMed ID: 15122774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimal hepatic encephalopathy.
    Sharma P
    J Assoc Physicians India; 2009 Nov; 57():760-3. PubMed ID: 20329443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimal hepatic encephalopathy: time to recognise and treat.
    Dhiman RK; Chawla YK
    Trop Gastroenterol; 2008; 29(1):6-12. PubMed ID: 18564660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-nitro-tyrosine as a peripheral biomarker of minimal hepatic encephalopathy in patients with liver cirrhosis.
    Montoliu C; Cauli O; Urios A; ElMlili N; Serra MA; Giner-Duran R; González-Lopez O; Del Olmo JA; Wassel A; Rodrigo JM; Felipo V
    Am J Gastroenterol; 2011 Sep; 106(9):1629-37. PubMed ID: 21483460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis.
    Sharma P; Sharma BC; Sarin SK
    Liver Int; 2009 Oct; 29(9):1365-71. PubMed ID: 19555401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal hepatic encephalopathy.
    Stewart CA; Smith GE
    Nat Clin Pract Gastroenterol Hepatol; 2007 Dec; 4(12):677-85. PubMed ID: 18043677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimal hepatic encephalopathy runs a fluctuating course: results from a three-year prospective cohort follow-up study.
    Tan HH; Lee GH; Thia KT; Ng HS; Chow WC; Lui HF
    Singapore Med J; 2009 Mar; 50(3):255-60. PubMed ID: 19352567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy.
    Sharma P; Sharma BC; Puri V; Sarin SK
    J Hepatol; 2007 Jul; 47(1):67-73. PubMed ID: 17459511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy.
    Montoliu C; Piedrafita B; Serra MA; del Olmo JA; Urios A; Rodrigo JM; Felipo V
    J Clin Gastroenterol; 2009 Mar; 43(3):272-9. PubMed ID: 18562979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extrapyramidal signs predict the development of overt hepatic encephalopathy in patients with liver cirrhosis.
    Compañy L; Zapater P; Pérez-Mateo M; Jover R
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):519-25. PubMed ID: 20010298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of altered oral glutamine challenge in patients with minimal hepatic encephalopathy.
    Romero-Gómez M; Grande L; Camacho I
    Hepatology; 2004 Apr; 39(4):939-43. PubMed ID: 15057897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum metabolic signature of minimal hepatic encephalopathy by (1)H-nuclear magnetic resonance.
    Jiménez B; Montoliu C; MacIntyre DA; Serra MA; Wassel A; Jover M; Romero-Gomez M; Rodrigo JM; Pineda-Lucena A; Felipo V
    J Proteome Res; 2010 Oct; 9(10):5180-7. PubMed ID: 20690770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory control test is a simple method to diagnose minimal hepatic encephalopathy and predict development of overt hepatic encephalopathy.
    Bajaj JS; Saeian K; Verber MD; Hischke D; Hoffmann RG; Franco J; Varma RR; Rao SM
    Am J Gastroenterol; 2007 Apr; 102(4):754-60. PubMed ID: 17222319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychological and neurophysiological evaluation in cirrhotic patients with minimal hepatic encephalopathy undergoing liver transplantation.
    Senzolo M; Amodio P; D'Aloiso MC; Fagiuoli S; Del Piccolo F; Canova D; Masier A; Bassanello M; Zanus G; Burra P
    Transplant Proc; 2005 Mar; 37(2):1104-7. PubMed ID: 15848636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychological impairment in severe acute viral hepatitis is due to minimal hepatic encephalopathy.
    Sharma P; Sharma BC; Tyagi P; Kumar M; Sarin SK
    Liver Int; 2009 Feb; 29(2):260-4. PubMed ID: 18710429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal hepatic encephalopathy in patients with decompensated liver cirrhosis.
    Marić D; Klasnja B; Filipović D; Brkić S; Ruzić M; Bugarski V
    Acta Clin Croat; 2011 Sep; 50(3):375-80. PubMed ID: 22384773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimal hepatic encephalopathy: consensus statement of a working party of the Indian National Association for Study of the Liver.
    Dhiman RK; Saraswat VA; Sharma BK; Sarin SK; Chawla YK; Butterworth R; Duseja A; Aggarwal R; Amarapurkar D; Sharma P; Madan K; Shah S; Seth AK; Gupta RK; Koshy A; Rai RR; Dilawari JB; Mishra SP; Acharya SK;
    J Gastroenterol Hepatol; 2010 Jun; 25(6):1029-41. PubMed ID: 20594216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.